These findings suggest that the reduction in DNA methylation levels in the promoter region may activate the expression of genes such as NPPA and NPPB by modulating the interactions of transcription factors like KLF4 and HIF1A, thereby contributing to the regulatory network associated with DCM-HF. This evidence concerns the gene KLF4 and familial dilated cardiomyopathy.